Advanced & Cell Therapy
One of many biotechnology disciplines, Advanced Therapy uses human cells to treat patients' illnesses. These may be either the patient's own cells (autologous therapy) or someone else's cells (allogenic therapy). Current research focuses largely on the use of stem cells. Human stem embryonic cells are pluripotent, which means that they are capable of differentiating all types of cells and tissues derived from three primary embryonic layers: the endoderm, mesoderm and ectoderm.
Human stem cells offer the option for tissue renewal and regeneration. They are used to treat a range of diseases, conditions and disabilities, including Parkinson's Disease and Alzheimer's Disease, spinal cord injuries, strokes, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis when properly employed.
The key factor is using the cells under specified conditions, with accurate timing and selection of their growth environment. Safe, quality production is ensured by building and maintaining facilities subject to strict regulations (so - called "Clean Rooms").
We are introducing a brand new term: Bioimplantology. It refers to the of applications of cell and tissue based products and the development of novel medical treatments utilising ATMP.
PrimeCell Therapeutics vision of the future of the Advanced Therapy field
Healthcare is heading into a new era, using human cells for the treatment of acute and chronic human disease in a natural way. The traditional chemical preparations, drugs and artificial materials used by current medicine will be just that, a thing of the past.
Biotechnologies, nanotechnologies and advanced therapies are the trend of the future, but they're also here in the present. New possibilities for treating diseases that have been diagnosed as untreatable until now, fatal conditions, cancers and prolonging life expectancy are all opening up.
We plan to go beyond the limits of tissue engineering and prolong human life expectancy. We are further developing organ engineering, creating complex organ structures by using new materials and human cells.
PrimeCell Therapeutics sphere of activity within the field of Advanced Therapy
PrimeCell Therapeutics operates in the area of Advanced Therapy in accordance with precise specifications given by the EU directives. These govern somatic-cell therapy, tissue engineering and gene therapy. PrimeCell Therapeutics combines these medical fields with material engineering - thus with new materials such as nanotechnology. We undertake multidisciplinary development and production in top development and production facilities in the Czech Republic.